Your browser doesn't support javascript.
loading
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mouritzen, Mette T; Junker, Karen F; Carus, Andreas; Ladekarl, Morten; Meldgaard, Peter; Nielsen, Anders W M; Livbjerg, Anna; Larsen, Jacob W; Skuladottir, Halla; Kristiansen, Charlotte; Wedervang, Kim; Schytte, Tine; Hansen, Karin H; Østby, Anne-Cathrine; Frank, Malene S; Lauritsen, Jakob; Sørensen, Jens B; Langer, Seppo W; Persson, Gitte F; Andersen, Jon L; Homann, Pernille H; Kristensen, Emilie B; Drivsholm, Lars B; Bøgsted, Martin; Christensen, Heidi S; Pøhl, Mette; Bjørnhart, Birgitte.
Afiliação
  • Mouritzen MT; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.
  • Junker KF; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Carus A; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Ladekarl M; Department of Oncology, Copenhagen E, Denmark.
  • Meldgaard P; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.
  • Nielsen AWM; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Livbjerg A; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Larsen JW; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.
  • Skuladottir H; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Kristiansen C; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Wedervang K; Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.
  • Schytte T; Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.
  • Hansen KH; Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.
  • Østby AC; Department of Oncology, Region Hospital West Jutland, Herning, Denmark.
  • Frank MS; Department of Oncology, Region Hospital West Jutland, Herning, Denmark.
  • Lauritsen J; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
  • Sørensen JB; Department of Oncology, Hospital Sønderjylland, Sønderborg, Denmark.
  • Langer SW; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Persson GF; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Andersen JL; Odense Patient data Explorative Network (OPEN), Odense, Denmark.
  • Homann PH; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Kristensen EB; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Drivsholm LB; Odense Patient data Explorative Network (OPEN), Odense, Denmark.
  • Bøgsted M; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Roskilde, Denmark.
  • Christensen HS; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Roskilde, Denmark.
  • Pøhl M; Department of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmark.
  • Bjørnhart B; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Roskilde, Denmark.
Acta Oncol ; 61(4): 409-416, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35012430

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca